Halozyme Therapeutics Inc.’s recently made public that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported $0.42 million on Mar 13 ’24. In the deal valued at $42.27 per share,10,000 shares were sold. As a result of this transaction, LaBarre Michael J. now holds 156,558 shares worth roughly $6.04 million.
Then, LaBarre Michael J. sold 10,000 shares, generating $416,370 in total proceeds. Upon selling the shares at $41.64, the SVP, CHIEF TECHNICAL OFFICER now owns 156,558 shares.
Before that, LaBarre Michael J. sold 10,000 shares. Halozyme Therapeutics Inc. shares valued at $395,463 were divested by the SVP, CHIEF TECHNICAL OFFICER at a price of $39.55 per share. As a result of the transaction, LaBarre Michael J. now holds 156,558 shares, worth roughly $6.04 million.
TD Cowen initiated its Halozyme Therapeutics Inc. [HALO] rating to an Outperform in a research note published on February 29, 2024; the price target was $54. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Goldman also remained covering HALO and has decreased its forecast on July 24, 2023 with a “Neutral” recommendation from previously “Buy” rating. Piper Sandler revised its rating on May 10, 2023. It rated HALO as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of HALO
On Friday, Halozyme Therapeutics Inc. [NASDAQ:HALO] saw its stock fall -1.81% to $38.61. Over the last five days, the stock has lost -5.99%. Halozyme Therapeutics Inc. shares have risen nearly 4.46% since the year began. Nevertheless, the stocks have risen 6.25% over the past one year. While a 52-week high of $45.00 was reached on 03/13/24, a 52-week low of $29.85 was recorded on 02/05/24. SMA at 50 days reached $39.05, while 200 days put it at $38.73. A total of 0.78 million shares were traded, compared to the trading of 0.73 million shares in the previous session.
Levels Of Support And Resistance For HALO Stock
The 24-hour chart illustrates a support level at 38.33, which if violated will result in even more drops to 38.06. On the upside, there is a resistance level at 39.08. A further resistance level may holdings at 39.56. The Relative Strength Index (RSI) on the 14-day chart is 40.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.39%. Stochastics %K at 9.78% indicates the stock is a buying.
